The mortality rate from malignant neoplasms among males in the Netherlands is expected to gradually increase from 24.94 thousand in 2024 to 25.49 thousand by 2028. This steady rise indicates an annual increase ranging between 0.56% and 0.57% year-on-year.
In 2023, the mortality level was slightly lower than the forecasted value for 2024, marking a trend of consistent annual growth. Specifically, the compound annual growth rate (CAGR) over the past five years is approximately 0.56%, showing a persistent incremental rise.
Future trends to watch include the potential impact of advancements in cancer treatment, early detection methods, and public health initiatives aimed at reducing cancer risk factors, which may alter these projections.
